◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › CNC

Centene Corp (CNC) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Managed Health Care · DATA UPDATED 2026-07-15

Centene Corp (CNC) operates in the Managed Health Care industry and is headquartered in Saint Louis, United States with about 61,000 employees. Its market capitalization is roughly $31 billion. In the fiscal year ended 2025-12-31, CNC reported $194.8B in revenue and ($6.7B) in net income.

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.

Interactive charts & full statements → Open the CNC valuation workbench →

CNC Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$198.1B$194.8B$163.1B$154.0B$144.5B$126.0B$111.1B$74.6B$60.1B$48.4B$40.6B$22.8B$16.6B$10.9B$8.1B$5.2B$4.4B$4.1B$3.4B$2.8B$2.3B
Gross Profit$29.6B$23.8B$16.8B$31.5B$16.7B$14.2B$15.2B$8.8B$8.4B$5.8B$5.5B$2.7B$1.9B$1.2B$813M$782M$635M$879M$667M$517M$398M
Gross Margin %14.9%12.2%10.3%20.5%11.5%11.3%13.7%11.8%14.0%12.0%13.7%12.1%11.5%11.1%10.0%15.0%14.3%21.4%19.8%18.7%17.5%
Operating Income (EBIT)($7.3B)($7.6B)$3.2B$2.9B$1.3B$1.8B$3.1B$1.8B$1.5B$1.2B$1.3B$705M$464M$277M$108M$204M$157M$138M$132M$55M($29M)
Operating Margin %-3.7%-3.9%1.9%1.9%0.9%1.4%2.8%2.4%2.4%2.5%3.1%3.1%2.8%2.5%1.3%3.9%3.5%3.4%3.9%2.0%-1.3%
Net Income($6.4B)($6.7B)$3.3B$2.7B$1.2B$1.3B$1.8B$1.3B$900M$828M$562M$355M$271M$165M$2M$111M$95M$84M$83M$73M($44M)
Net Margin %-3.2%-3.4%2.0%1.8%0.8%1.1%1.6%1.8%1.5%1.7%1.4%1.6%1.6%1.5%0.0%2.1%2.1%2.0%2.5%2.6%-1.9%
EBITDA($4.4B)($5.1B)$6.2B$2.9B$4.1B$3.8B$4.8B$2.8B$2.2B$1.8B$1.7B$851M$581M$363M$209M$267M$224M$198M$189M$108M$10M
Earnings Per Share (EPS)$-13.14$-13.59$6.31$4.95$2.07$2.28$3.12$3.14$2.26$2.35$1.71$1.44$1.13$0.73$0.01$0.53$0.47$0.47$0.47$0.41$-0.25
Shares Outstanding (M)496M491M524M546M582M591M579M420M399M353M328M246M241M225M215M210M202M177M178M179M173M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CNC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$49.9B$49.7B$49.7B$48.7B$46.6B$40.8B$42.0B$39.8B
Gross Profit$10.9B$7.5B$8.1B$2.9B$5.2B$3.7B$4.0B$4.4B
Gross Margin %21.9%15.2%16.4%6.0%11.2%9.1%9.6%11.1%
Operating Income (EBIT)$1.9B($1.7B)($7.0B)($458M)$1.5B$175M$665M$1.2B
Operating Margin %3.7%-3.5%-14.0%-0.9%3.3%0.4%1.6%3.1%
Net Income$1.5B($1.1B)($6.6B)($253M)$1.3B$283M$713M$1.1B
Net Margin %3.1%-2.2%-13.3%-0.5%2.8%0.7%1.7%2.9%
EBITDA$2.6B($1.0B)($6.2B)$228M$2.2B$833M$1.4B$2.0B
Earnings Per Share (EPS)$3.11$-2.24$-13.50$-0.51$2.63$0.56$1.36$2.16
Shares Outstanding (M)496M491M491M494M498M502M524M531M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CNC Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$7.2B$5.1B$154M$8.1B$6.3B$4.2B$5.5B$1.5B$1.2B$1.5B$1.9B$658M$1.2B$383M$279M$262M$169M$248M$222M$202M$195M
Capital Expenditures (CapEx)$832M$767M$644M$799M$1.0B$910M$869M$730M$675M$422M$306M$150M$103M$68M$82M$74M$119M$83M$65M$54M$50M
Free Cash Flow (FCF)$6.3B$4.3B($490M)$7.3B$5.3B$3.3B$4.6B$753M$559M$1.1B$1.5B$508M$1.1B$315M$197M$188M$50M$165M$157M$148M$145M
FCF Margin %3.2%2.2%-0.3%4.7%3.6%2.6%4.2%1.0%0.9%2.2%3.8%2.2%6.8%2.9%2.4%3.6%1.1%4.0%4.7%5.4%6.3%
Dividends Paid$88M$35M$6.1B$66M$0M$0M$0M$189M$0M$0M$7M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CNC Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$3.6B$437M$1.4B$1.8B$1.5B($587M)($978M)$2.2B
Capital Expenditures (CapEx)$200M$213M$211M$208M$135M$154M$153M$186M
Free Cash Flow (FCF)$3.4B$224M$1.1B$1.6B$1.4B($741M)($1.1B)$2.0B
FCF Margin %6.8%0.4%2.3%3.2%2.9%-1.8%-2.7%5.0%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CNC Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$81.2B$77.7B$82.4B$84.6B$76.9B$78.4B$68.7B$41.0B$30.9B$21.9B$20.2B$7.3B$5.8B$3.5B$2.7B$2.2B$1.9B$1.7B$1.5B$1.1B$895M
Cash & Cash Equivalents$21.3B$17.9B$14.1B$17.2B$12.1B$13.1B$10.8B$12.1B$5.3B$4.1B$3.9B$1.8B$1.6B$1.0B$844M$574M$434M$404M$379M$269M$271M
Total Liabilities$59.6B$57.6B$55.9B$58.7B$52.6B$51.4B$42.8B$28.3B$19.9B$15.0B$14.1B$5.0B$3.9B$2.3B$1.8B$1.3B$1.1B$1.1B$950M$704M$569M
Total Debt (Short + Long-Term)$16.4B$17.5B$18.7B$18.0B$18.2B$19.0B$17.0B$13.9B$6.7B$4.7B$4.7B$1.2B$893M$669M$539M$352M$331M$308M$265M$207M$176M
Total Shareholders' Equity$21.4B$20.0B$26.4B$25.8B$24.1B$26.8B$25.8B$12.6B$10.9B$6.8B$5.9B$2.2B$1.7B$1.2B$953M$936M$794M$601M$501M$415M$326M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CNC viewer.

Other Companies in Managed Health Care

← CNAAll stocksCNCK →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.